Skip to main content
SpringerLink
Log in

Probiotics Reduce Bacterial Colonization and Gastric Inflammation in H. pylori-Infected Mice

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Probiotics are characterized by their ability to interact with commensal microflora in the gastrointestinal tract to produce beneficial health effects. In vitro studies suggest that Lactobacillus species have the potential to suppress the growth of Helicobacter pylori. The goal of this study was to determine if pretreatment of mice with a commercial mixture of live probiotics (L. rhamnosus, strain R0011, and L. acidophilus, strain R0052) would suppress colonization of H. pylori, strain SS1. Thirty C57BL/6 female mice were divided into four groups: Group A was fed sterile water, group B received probiotics in sterile drinking water, group C was challenged orogastrically with H. pylori, and group D was pretreated with probiotics in drinking water prior to and following challenge with H. pylori. Rectal swabs, stomach homogenates, and luminal contents from ileum and colon were plated onto colistin nalidixic acid plates. Serial dilutions of stomach homogenates were plated onto H. pylori-sensitive agar plates and incubated under microaerophilic conditions. Tissue samples from the stomach were analyzed histologically to determine the degree of H. pylori colonization, mucosal inflammation, and epithelial cell apoptosis. Probiotics in drinking water did not affect the overall well-being of mice. Lactobacillus species were excreted in stools over the entire duration of treatment. Pretreatment with probiotics reduced the number of mice with H. pylori growth from stomach homgenates (100 to 50%; P = 0.02). The percentage of mice with moderate-severe H. pylori-induced inflammation in the gastric antrum was reduced with probiotic pretreatment (71 to 29%; P = 0.14). However, pretreatment with probiotics did not prevent H. pylori-induced apoptosis in the gastric mucosa. This preparation of probiotics provided a safe and novel approach for reducing H. pylori colonization and bacterial-induced inflammation of mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Metchnikoff E: The prolongation of life: optimistic studies. InC Mitchell (ed). Prolongation of Life. London, William Heinemann, 1907, pp 161–183

    Google Scholar 

  2. Guarner F, Malagelada JR: Gut flora in health and disease. Lancet 361(9356):512–519, 2003

    Google Scholar 

  3. Prajapati JB, Nair BM: The history of fermented foods. In Handbook of Fermented Foods. ER Farnworth (ed). Boca Raton, FL, CRC Press, 2003, pp 1–25

    Google Scholar 

  4. Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, Brigidi P, Vitali B, et al.: Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo controlled trial. Gastroenterology 124:1202–1209, 2003

    Google Scholar 

  5. Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J: Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 73 (Suppl2):430S–436S, 2001

    Google Scholar 

  6. Huang, JS, Athos B; Lee JW, Diaz A, Davidson EJ: Efficacy of probiotic use in acute diarrhea in children: A meta-analysis. Dig Dis Sci 47(11):2625–2634, 2002

    Google Scholar 

  7. Van Neil CW, Feudtner C, Garrison MM, ChristakisDA: Lactobacillus therapy for acute infectious diarrhea in children:Ameta-analysis. Pediatrics 109:678–684, 2002

    Google Scholar 

  8. Suerbaum S, Michetti P: Helicobacter pyloriinfection. N Engl J Med 347:1175–1186, 2002

    Google Scholar 

  9. NIH Consensus Development Panel on Helicobacter pyloriin Peptic Ulcer Disease. JAMA 272:65, 1994

    Google Scholar 

  10. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Masson A, et al.: Helicobacter pylori, a paradigm for chronic mucosal inflammation and prevention. Adv Intern Med 41:85–117, 1996

    Google Scholar 

  11. Chatterjee A, Yasmin T, Bagchi D, Stohs S: The bactericidal effects of Lactobacillus acidophilus, garcinol and Protykin®?compared to clarithromycin, on Helicobacter pylori.Mol Cell Biol 243:29–35, 2003

    Google Scholar 

  12. Johnson-Henry K, Tompkins T, Sherman P: Effect of lactobacillus on enterohemorrhagic Esherichia coli-induced alterations in intestinal epithelial cell permeability. Annu Meet Am Soc Microbiol, Orlando, FL, 2001, abstr B-188

  13. Lee A, O'Rourke J, Ungaria MC, Robertson B, Daskalopoulos G, Dixon MF: A standardized mouse model of Helicobacter pyloriinfection: Introducing the Sydney strain. Gastroenterology 112:1386–1397, 1997

    Google Scholar 

  14. Jones N, Day A, Jennings HA, Sherman PM: Helicobacter pyloriinduces gastric epithelial cell apoptosis in association with increased Fas receptor expression. Infect Immun 67:4237–4242, 1999

    Google Scholar 

  15. Schillinger U, Lucke FK: Antibacterial activity of Lactobacillus sakeisolated from meat. Appl Environ Microbiol 55(8):1901–1906, 1989

    Google Scholar 

  16. Cantey J, Hosterman D: Characterization of colonization of the rabbit gastrointestinal tract by Escherichia coliRDEC-1. Infect Immun 26(3):1099–1103, 1979

    Google Scholar 

  17. Jones N, Day A, Jennings HA, Shannon PT, Galindo-Mata E, Sherman PM: Enhanced disease severity in Helicobacter pyloriinfected mice deficient in Fas signaling. Infect Immun 70(5):2591–2597, 2002

    Google Scholar 

  18. P. Sutton, Wilson J, Lee A: Further development of the Helicobacter pylorimouse vaccination model. Vaccine 18:2677–2685, 2000

    Google Scholar 

  19. Drumm B, Sherman P, Cutz E, Karmali M: Association of Campylobacter pylorion the gastric mucosa with antral gastritis in children. N Engl J Med 316:1557–1561, 1987

    Google Scholar 

  20. Jax Notes: Malocculusion in the laboratory mouse. www.jax.org/ jaxmice

  21. Mercenier A, Pavan S, Pot B: Probiotics as biotherapeutic agents: Present knowledge and future prospects. Curr Pharm Design 8:99–110, 2002

    Google Scholar 

  22. Tomasik PJ, Tomasik P: Probiotics and prebiotics: Review. Cereal Chem 80:113–117, 2003

    Google Scholar 

  23. Kocian J: Lactobacilli in the treatment of dyspepsia in dysmicrobia of various aetiology. Vnitrni Lekarstvi 40:79–83, 1994

    Google Scholar 

  24. Bielanski W, Ziemniak W, Plonka M, Dobrzanska MJ, Kaminska A, Konturek SJ: Improvement of anti-Helicobacter pyloritherapy by the use of commercially available probiotics. Gut 51(11):A98, 2002

  25. Hamilton-Miller JMT: The role of probiotics in the treatment and prevention of Helicobacter pyloriinfection. Int J Antimicrobial Agents 22:360–366, 2003

    Google Scholar 

  26. Brzozowski T, Konturek P.C, Bielanski W, Kwiecien S, Drozdowicz D, Pajdo R, Konturek SJ: Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression and functional impairment in Helicobacter pylori(HP)-infected Mongolian gerbils. Annual AGA-DDW meeting, Orlando, FL, 2003, abstr M1501

  27. Fernandez MF, Boris S, Barbes C: Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. J Appl Microbiol 94(3):449–455, 2003

    Google Scholar 

  28. Saito N, Lpmosjo L, Sato F, Kato M, Takeda H, Sagiyama T, Asaka M: Plural transformation-processes from spiral to coccoid Helicobacter pyloriand its viability. J Infect 46(1):49–55, 2003

    Google Scholar 

  29. Stingl K, Uhlemann EM, Deckers-Hebestreit G, Schmid R, Bakker EP, Altendorf K: Prolonged survival and cytoplasmic pH homeostasis of Helicobacter pyloriat pH1. Infect Immun 69:1178–11180, 2001

    Google Scholar 

  30. Sachs G, Weeks DL, Melchers K, Scott DR: The gastric biology of Helicobacter pylori.Annu Rev Phisiol 65:349–369, 2003

    Google Scholar 

  31. Sgouras D, Maragkoudakis P, Petraki D, Martinez-Gonzalez B, Eriotou E, Michopoulos S, Kalantzopoulos G, Tsakalidou E, Mentis A: In vitroand in vivoinhibition of Helicobacter pyloriby Lactobacillus caseistrain Shirota. Appl Environ Microb 70:518–526, 2004

    Google Scholar 

  32. Mangell P, Nejdfors P, Wang M, Ahrne S, Westrom B, Thorlacius H, Jeppsson B: Lactobacillus plantarum299v inhibits Escherichia coli-induced intestinal permeability. Dig Dis Sci 47(3):511–516, 2002

    Google Scholar 

  33. Fried LF, Palevsky PM: Renal disease. Med Clin NoAm 81(3):585–609, 1997

    Google Scholar 

  34. De Waard R, Snel J, Bokken GC, Tan PS, Schut F, Huis In't Veld JH: Comparison of faecal Lactobacillus populations in experimental animals from different breeding facilities and possible consequences for probiotic studies. Left Appl Microbiol 34(2):105–109, 2002

    Google Scholar 

  35. Dieleman L, GoerresM, Arends A, Sprengers D, Torrice C, Hoentjen F, Grenther WB, et al.: LactobacillusGG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 52(3):370–376, 2003

    Google Scholar 

  36. Yuki N, Shimazaki T, Kushiro A, Watanabe K, Uchida K, Yuyama T, Morotomi M: Colonization of the stratified squamous epithelium of the nonsecreting area of the horse stomach by lactobacilli. Appl Environ Microbiol 66(11):5030–5034, 2000

    Google Scholar 

  37. Wu JJ, Lo CY, Wu HW, Chen JH, Lin YS, Lin MD: Impact of supplement with Lactobacillusand Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylorieradication. Aliment Pharmacol Ther 16:1669–1675, 2002

    Google Scholar 

  38. Isolauri E: Probiotics for infectious diarrheoea. Gut 52:436–437, 2003

    Google Scholar 

  39. Bezkorovainy A: Probiotics: Determinants of survival and growth in the gut. Am J Clin Nutr 73:399S–405S, 2001

    Google Scholar 

  40. Resta-Lenert S, Barrett K: Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli(EIEC). Gut 52:988–997, 2003

    Google Scholar 

  41. Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA: Probiotics inhibit enteropathogenic E. coliadherence in vitroby inducing intestinal mucin gene expression. AmJ Physiol 276;G941–G950, 1999

    Google Scholar 

  42. Johnson-Henry K, Tompkins TA, Sherman PM: Lactobacillus species inhibit adherence of enteropathogenic Escherichia coliand enterohemorrhagic E. colito host epithelial cells. Annual meeting of the Danone Symposium on Fermented Food, Fermentation and Intestinal Flora, New York, 2000, abstr 7

  43. Sutton P, Wilson J, Lee A: Further development of Helicobacter pylorimouse vaccination model. Vaccine 18:2677–2685, 2000

    Google Scholar 

  44. Garhart CA, Redline RW, Nedrud JG, Czinn SJ: Clearance of Helicobacter pyloriinfection and resolution of postimmunization gastritis in a kinetic study of prophylactically immunized mice. Infect Immun 70:3529–3538, 2002

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Toronto, Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada

    Kathene Candace Johnson-Henry, David J. Mitchell, Yaron Avitzur, Esther Galindo-Mata, Nicola L. Jones & Philip M. Sherman

Authors
  1. Kathene Candace Johnson-Henry
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David J. Mitchell
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yaron Avitzur
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Esther Galindo-Mata
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nicola L. Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Philip M. Sherman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Johnson-Henry, K.C., Mitchell, D.J., Avitzur, Y. et al. Probiotics Reduce Bacterial Colonization and Gastric Inflammation in H. pylori-Infected Mice. Dig Dis Sci 49, 1095–1102 (2004). https://doi.org/10.1023/B:DDAS.0000037794.02040.c2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:DDAS.0000037794.02040.c2

Search

Navigation